Effects of Gamma-hydroxybutyric acid (GHB) in opioid-dependent patients

Journal of Substance Abuse Treatment

Volumn 14, Issue 2, 1997, Pages 149-154

  Rosen, Marc I ^a,b   Pearsall, H Rowland ^a   Woods, Scott W ^a   Kosten, Thomas R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Abuse liability; Gamma hydroxybutyric acid (GHB); Sedative

Indexed keywords

4 HYDROXYBUTYRIC ACID; ALCOHOL; BENZODIAZEPINE DERIVATIVE; DOPAMINE; NALOXONE; OPIATE; OPIATE RECEPTOR;

ABUSE; ADULT; ARTICLE; CLINICAL ARTICLE; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG WITHDRAWAL; GABAERGIC SYSTEM; HUMAN; MALE; MOOD; NARCOTIC DEPENDENCE; PRIORITY JOURNAL; SLEEP INDUCTION;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HEROIN DEPENDENCE; HUMANS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NEUROLOGIC EXAMINATION; PREMEDICATION; SODIUM OXYBATE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030811315     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0740-5472(96)00157-2     Document Type: Article

References (41)

1. Aldrete, J.A., & Barnes, D.P. (1968). Four-hydroxybutyrate anaesthesia for cardiovascular surgery. A comparison with halothane. Anaesthesia, 23, 558-565.
2. Banerjee, P.K., & Snead, O.C. (1995). Presynaptic gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acid-B (GABAB) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): A possible mechanism for the generation of absence-like seizures induced by GHB. Journal of Pharmacology and Experimental Therapeutics, 273, 1534-1543.
3. Beardsley, P.M., Nicholsan, K., Cook, C.D., Freakes, M., Harris, L.S., Balster, R.L., & Hua, L. (1995). The reinforcing and discriminative stimulus effects of gammahydroxybutyric acid (GHB). College on Problems of Drug Dependence, (presented abstract).
4. Benavides, J., Rumigny, J.F., Bourguignon, J.J., Case, C., Wermuth, C.G., Mandel, P., Vincendon, G., & Maitre, M. (1982). High affinity binding site for gamma-hydroxybutyric acid in rat brain. Life Sciences, 30, 953-961.
5. Bickel, W.K., Bigelow, G.E., Preston, K.L., & Liebson, I.A. (1989). Opioid drug discrimination in humans: Stability, specificity, and relation to self-reported drug effect. Journal of Pharmacology and Experimental Therapeutics, 251, 1053-1063.
6. Blumenfeld, M., Suntay, R.G., & Harmel, M.H. (1962). Sodium gamma-hydroxybutyric acid: A new anesthetic adjuvant. Anesthesia and Analgesia . . . Current Researches, 41, 721-726.
7. Center for Disease Control. (1991). Multistate outbreak of poisonings associated with illicit use of gamma-hydroxybutyrate. Journal of the American Medical Association, 265, 447-448.
8. Cohen, J. (1988). Statistical power analysis for the behavioral sciences. (2nd ed.). Hillside, NJ: Lawrence Erlbaum Associates.
9. Colombo, G., Agabio, R., Lobina, C., Reali, R., Fadda, F., & Gessa, G.L. (1995). Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: Occurrence within narrow dose ranges. Physiology & Behavior, 57, 105-111.
10. Crosby, G., Ito, M., Kaufman, E., Nelson, T., & Sokoloff, L. (1983). Naloxone pretreatment alters the local cerebral metabolic effect of gamma-hydroxybutyrate in rats. Brain Research, 275, 194-197.
11. Devoto, P., Colombo, G., Cappai, F., & Gessa, L. (1994). Naloxone antagonizes ethanol-but not gamma-hydroxybutyrate-induced sleep in mice. European Journal of Pharmacology, 252, 321-324.
12. Doherty, J.D., Hattox, S.E., Snead, O.C., & Roth, R.H. (1978). Identification of endogenous and gamma-hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig, and rhesus monkey brain. Journal of Pharmacology and Experimental Therapeutics, 207, 130-139.
13. Engberg, G., & Nissbrandt, H. (1993). Gamma-hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors. Naunyn-Schmiedebergs Archives of Pharmacology, 348, 491-497.
14. Frederick, S.L., Galloway, G.P., & Staggers, F.E. (1994). Gamma-hydroxybutyrate: A putative neurotransmitter that is abused and causes physical dependence. College on the Problems of Drug Dependence, (presented poster).
15. Gallimberti, L., Ganton, O, Gentile, N., Ferri, M , Cibin, M. Fadda, F. Ferrare, S.D., & Gessa, G.L. (1989). Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet, 11, 787-789.
16. Gallimberti, L., Cibin, M., Pagnin, P., Sabbion, R., Pani, P.P., Pirastu, R., Ferrara, S.D., & Gessa G.L. (1993). Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology, 9, 77-81.
17. Galloway, G.P., Frederick, S.L., & Staggers, F. (1994). Physical dependence on sodium oxybate (letter). Lancet, 343, 57.
18. Gerra, G., Caccavari, R., Fontanesi, B., Marcato, A., Affini, G.F., Maestri, D., Avanzini, P., Lecchini, R., Delsignore, R., & Mutti, A. (1994). Flumazenil effects on growth hormone response to gamma-hydroxybutyric acid. International Clinical Psychopharmacology, 9, 211-215.
19. Hechler, V., Gobaille, S., Bourguignon, J.J., & Maitre, M. (1991). Extracellular events induced by gamma-hydroxybutyrate in striatum: A microdialysis study. Journal of Neurochemistry, 56, 938-944.
20. Hechler, V., Peter, P., Gobaille, S., Bourguignon, J., Schmitt, M., Ehrhardt, J., Mark, J., & Maitre, M. (1993). Gamma-hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities. Journal of Pharmacology and Experimental Therapeutics, 264, 1406-1414.
21. Jasinski, D.R., Martin, W.R., & Mansky, P.A. (1971). Progress report on the assessment of the antagonists nalbuphine and GPA-2087 for abuse potential and studies of the effects of dextromethorphan in man. Committee on Problems of Drug Dependence, 1, 143-178.
22. Levitt, S., Benet, L., Stambler, L., Dodd, J., Stone, J., & Sider, D. (1993). River's end. People Magazine, 40, 126-133.
23. Mack, R.B. (1993). Gamma-hydroxybutyrate poisoning. North Carolina Medical Journal, 54(5), 232-233.
24. Maitre, M., Rumigny, J.F., Cash, C.D., & Mandel, P. (1983). Subcellular distribution of gamma-hydroxybutyrate binding sites in rat brain: Principal localization in the synaptosomal fraction. Biochemical and Biophysical Research Communications, 110, 262-265.
25. Mamelak, M., Scharf, M.B., & Wods, M. (1986). Treatment of narcolepsy with gamma-hydroxybutyrate: A review of clinical and sleep laboratory findings. Sleep, 9, 285-289.
26. Metcalf, D.R., Emde, R.N., & Stripe, J.T. (1966). An EEG-behavioral study of sodium hydroxybutyrate in humans. Electroencephalography and Clnical Neuropsychology, 20, 506-512.
27. Nelson, T., Kaufman, E., Kline, J., & Sokoloff, L. (1981). The extraneuronal distribution of gamma-hydroxybutyrate. Jourmal of Neurochemistry, 37, 1345-1348.
28. Palatini, P., Tedeschi, L., Frison, g., Padrini, R., Zordan, R., Orlando, R., Gallimberti, L., Gessa, G., & Ferrara, S. D. (1993). Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. European Journal of Clinical Pharmacology, 45, 353-356.
29. Papavasiliou, P.S., Cotzias, G.C., Mena, I., & Bell, M. (1973). Oxybate sodium for parkinsonism. Journal of the American Medical Association, 224(1), 130.
30. Rosen M.I., Pearsall, H.R., Woods, S.W., & Kosten T.R. (1996). The effect of gammahydroxybutyric acid on naloxone-precipitated opiate withdrawal. Neuropsychopharmacology, 14(3), 187-193.
31. Schmidt, C., Gobaille, S., Hechler, V., Schmidt, M., Bourguignon, J.J., & Maitre, M. (1991). Anti-sedative and anti-cataleptic properties of NCS-382, a gammahydroxybutyrate receptor antagonist. European Journal of Pharmacology, 203, 393-397.
32. Sherman, A.D., & Gebhart, G.F. (1975). An evaluation of the analgesia induced by morphine and gamma-hydroxybutyrate. Archives Internationales de Pharmacodynamie et de Therapie, 213(2), 195-199.
33. Snead, O.C. (1977). Minireview: Gamma hydroxybutyrate. Life Sciences, 20, 1935-1944.
34. Snead, O.C., & Bearden, L.J. (1980). Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate. Neurology, 30, 832-838.
35. Strain, E.C., Preston, K.L, Liebson, I.A., & Bigelow, G.E. (1992). Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers. Journal of Pharmacology and Experimental Therapeutics, 261, 985-993.
36. Tunnicliff, G. (1992). Significance of gamma-hydroxybutyric acid in the brain. General Pharmacology, 23, 1027-1034.
37. United States Pharmaceutical Convention, Inc. (1990). USP dispensing information. Vol. 1B, Drug information for the health care professional (pp. 2914).
38. Vickers, M.D. (1969). Gammahydroxybutyric acid. International Anesthesiology Clinics, 7, 75-89.
39. Walters, J.R., & Roth, R.H, (1972). Effect of gamma-hydroxybutyrate on dopamine metabolites in the rat striatum. Biochemical Pharmacology, 21, 2111-2121.
40. Wilkinson, P. (1994). The young and the reckless. Rolling Stone, 681, 29-30.
41. Winter, J.C. (1981). The stimulus properties of gamma-hydroxybutyrate. Psychopharmacology, 73, 372-375.